Derivation of Metabolically Active Hepatocytes from Human Pluripotent Stem Cells
.
In this webinar Dr. David Hay, of the MRC Centre for Regenerative Medicine at the University of Edinburgh, presents data on the derivation of definitive endoderm from human pluripotent stem cells and its further differentiation into metabolically active hepatocytes. He also discusses the applications of this research for drug development and cell therapy.
Publish Date:
July 16, 2013
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
STEMdiff™: Products for Differentiating Human Pluripotent Stem Cells
Publish Date: June 27, 2011 -
ISSCR 2011 Innovation Showcase - STEMdiff™ APEL™ Medium
Publish Date: June 30, 2011
Explore Our Products
-
STEMdiff™ Definitive Endoderm Kit
Defined animal component-free medium for the differentiation of human ES and iPS cells to definitive endoderm -
STEMdiff™ Definitive Endoderm Kit (TeSR™-E8™ Optimized)
Defined animal component-free medium for the differentiation of human ES and iPS cells maintained in TeSR™-E8™ to definitive endoderm
